How does the IRB handle noncompliance?
If the IRB finds significant violations during any of its reviews of research; the investigator will be notified immediately in writing by the IRB Chair. Enrollment in the study will cease until these violations are corrected. Any continuous or serious noncompliance with the IRB requirements by investigators must be relayed to the IRB Chair, Meriter Hospital and the appropriate regulatory agency. This will result in immediate suspension of the approved protocol. If the required annual review date has expired or if the investigator fails to correct the deficiencies in the annual review process, IRB approval will be terminated immediately.
